Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12968/hmed.2021.0047 http://scihub22266oqcxt.onion/10.12968/hmed.2021.0047 33646036!ä!33646036 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Hosp+Med+(Lond) 2021 ; 82 (2): 1-4 Nephropedia Template TP {{tp|p=33646036|t=2021. COVID-19 vaccines: what happened to evidence-based medicine?|pdf=|usr=}}{{33646036}} gab.com Text COVID-19 vaccines: what happened to evidence-based medicine JO: Br J Hosp Med (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=33646036 #FOAvip The UK government recently decided to extend the interval between the first dose of the Pfizer BioNTech and AstraZeneca COVID-19 vaccines from 3 weeks to 12 weeks to maximise the number of people receiving the initial dose, despite the trials only providing vaccine efficacy data based on a schedule of 21 days between doses. This editorial discusses whether there is evidence to support this policy change. Twit Text FOAVip COVID-19 vaccines: what happened to evidence-based medicine ????Br J Hosp Med (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=33646036 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33646036 #FOAvip English Wikipedia <ref>{{Cite pmid|33646036}}</ref> COVID-19 vaccines: what happened to evidence-based medicine? #MMPMID33646036 Quek E; Tahir H Br J Hosp Med (Lond) 2021[Feb]; 82 (2): 1-4 PMID33646036show ga The UK government recently decided to extend the interval between the first dose of the Pfizer BioNTech and AstraZeneca COVID-19 vaccines from 3 weeks to 12 weeks to maximise the number of people receiving the initial dose, despite the trials only providing vaccine efficacy data based on a schedule of 21 days between doses. This editorial discusses whether there is evidence to support this policy change. |*COVID-19 Vaccines/administration & dosage/immunology[MESH] |*COVID-19/epidemiology/immunology/prevention & control[MESH] |*Immunogenicity, Vaccine[MESH] |*Vaccination Coverage/methods/standards[MESH] |*Vaccination/methods/standards/statistics & numerical data[MESH] |Drug Administration Schedule[MESH] |Evidence-Based Medicine/methods/standards[MESH] |Government Regulation[MESH] |Health Policy/legislation & jurisprudence[MESH] |Humans[MESH] |Policy Making[MESH] |SARS-CoV-2[MESH]COVID-19 vaccines: what happened to evidence-based medicine?(epmc).pdf DeepDyve Pubget Overpricing